Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for erythropoietin-resistant anemia in hemodialysis patients
IRCT20100413003698N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anaemia comparing Pentoxifylline with Placebo (2 arms). Primary endpoints: Hemoglobin, Erythrocyte sedimentation rate and 1 more. Started Apr 2018; status: completed.
02
Drugs
pentoxifylline
03
Conditions
anaemia
Beyond the preview
Go deeper on IRCT20100413003698N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100413003698N2.